Option Care Health Inc - Company Profile
Powered by 
All the data and insights you need on Option Care Health Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Option Care Health Inc Strategy Report
- Understand Option Care Health Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Option Care Health Inc (Option Care Health) is a healthcare service provider that offers infusion therapy and other ancillary healthcare services. The company provides home infusion services and alternative site infusion services. Its services consist of anti-infectives, immunoglobulin therapy, bleeding disorder therapies, nutrition support, and other therapies for chronic and acute conditions. It also provides infusion therapy services such as nursing support, clinical management, and care coordination. It focuses on improving the quality of care and reducing patient healthcare costs. The hospital has operations in Florida, California, Georgia, Illinois, Kentucky, Massachusetts, Louisiana and Minnesota. Option Care Health is headquartered in Bannockburn, Illinois, the US.
Headquarters
United States of America
Address
3000 Lakeside Dr, Suite 300n, Bannockburn, Illinois, 60015
Website
optioncarehealth.com
Telephone
1 312 9402443
No of Employees
5,809
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
OPCH (NASD)
Revenue (2022)
$4.3B
9.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
77.4%
(2022 vs 2021)
Market Cap*
$5.3B
Net Profit Margin (2023)
XYZ
62.6%
(2022 vs 2021)
* As of and is in US$
Option Care Health Inc premium industry data and analytics
Products and Services
| Services |
|---|
| Anti-Infective Therapy |
| Immunoglobulin Therapy |
| Cardiac Care |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Others | In June, the company terminated its merger with Amedisys, Inc. |
| 2023 | Contracts/Agreements | In May, the company became a part of the limited distribution specialty pharmacy network of VYJUVEK, a topical gene therapy, developed by Krystal Biotech Inc. |
| 2023 | Contracts/Agreements | In May, the company entered into an agreement to merge with Amedisys. |
Competitor Comparison
| Key Parameters | Option Care Health Inc | CVS Health Corp | Accredo Health Group Inc | Community Health Group | Optum Specialty Pharmacy |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Bannockburn | Woonsocket | Memphis | Chula Vista | South Portland |
| State/Province | Illinois | Rhode Island | Tennessee | California | Maine |
| No. of Employees | 5,809 | 300,000 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Harry M. Jansen Kraemer, Jr. | Chairman | Executive Board | 2019 | 68 |
| John C. Rademacher | Chief Executive Officer; Director; President | Executive Board | 2019 | 56 |
| Mike Shapiro | Chief Financial Officer | Senior Management | 2015 | 52 |
| Luke Whitworth | Chief Operating Officer | Senior Management | - | - |
| Brett Michalak | Chief Information Officer | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward